Results 131 to 140 of about 10,389 (214)

Sex-Specific Association of Rasagiline with Motor Progression in <i>GBA1</i>-Associated Parkinson's Disease. [PDF]

Life (Basel)
Saragani H, Henner R, Becker-Cohen M, Revel-Vilk S, Zimran A, Harari I, Eichel R, Yahalom G, Cohen ME.   +8 more
europepmc   +1 more source

Glucocerebrosidase (GBA; GCase) [PDF]

Science-Business eXchange, 2014
openaire   +1 more source

Diagnosis and follow-up of the first case of Gaucher disease under enzyme replacement therapy in Senegal. [PDF]

Ghana Med J
Keita M, Faye BF, Senghor AB, Diallo AB, Bousso ES, Touré SA, Seck M, Diop S.   +7 more
europepmc   +1 more source

Crossing the barrier: nanomedicine as a frontier therapy for neuropathic Gaucher disease type 3. [PDF]

Ann Med Surg (Lond)
Saif M, Nasir A, Shafique S, Fatima M, Talha M.   +4 more
europepmc   +1 more source

Current and emerging drugs for Parkinson's disease: mechanisms, clinical evidence, and future directions. [PDF]

Front Pharmacol
Yang F.
europepmc   +1 more source

The Race to Salvage Glucocerebrosidase: Understanding Small-Molecule Therapies for GBA1-Associated Parkinsonism. [PDF]

Mov Disord
Henderson MJ, Chen TC, Glasstetter LM, Chen Y, Marugan JJ, Sidransky E.   +5 more
europepmc   +1 more source

Clinical course and biomarkers in patients with type 1 Gaucher disease and Parkinson's disease: A retrospective cohort study. [PDF]

Mol Genet Metab Rep
Iverson A, Sinha DB, Fierro L, Stauffer C, Naik H, Alcalay RN, Balwani M.   +6 more
europepmc   +1 more source

Gaucher disease: the hematologist's perspective of a multisystemic disorder. [PDF]

Ann Hematol
Costa A, Mulas O, Caocci G.
europepmc   +1 more source

Age-Specific Parkinson Disease Risk in Gaucher Disease Type 1: Data From the ICGG Gaucher Registry. [PDF]

Neurology
Alcalay RN, Mistry P, Di Fonzo A, Batista JL, Bianculli P, Carwile JL, Perichon MG, Balwani M.   +7 more
europepmc   +1 more source